Role of CD95 in pulmonary inflammation and infection in cystic fibrosis

Journal of Molecular Medicine

Volumn 90, Issue 9, 2012, Pages 1011-1023

  Becker, Katrin Anne ^a   Henry, Brian ^a   Ziobro, Regan ^a   Tümmler, Burkhard ^b   Gulbins, Erich ^a   Grassmé, Heike ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CD95; Cell death; Ceramide; Cystic fibrosis; Infection; Inflammation; Pseudomonas aeruginosa

Indexed keywords

CERAMIDE; FAS ANTIGEN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; DNA MODIFICATION; GENE ACTIVATION; GENE TARGETING; GENETIC ANALYSIS; HETEROZYGOSITY; LUNG FUNCTION; LUNG INFECTION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PSEUDOMONAS INFECTION; UPREGULATION;

ANIMALS; ANTIGENS, CD95; CELL DEATH; CERAMIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE DELETION; LUNG; MICE; MICE, INBRED C57BL; PNEUMONIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; UP-REGULATION;

EID: 84867334391     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-012-0867-2     Document Type: Article

References (39)

1. CF Foundation (2004) Patient registry annual report. CF Foundation, Bethesda
2. American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388-416
3. Ratjen F, Döring G (2003) Cystic fibrosis. Lancet 361:681-689
4. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080
5. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073
6. Matsui H, Verghese MW, Kesimer M, Schwab UE, Randell SH, Sheehan JK, Grubb BR, Boucher RC (2005) Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces. J Immunol 175:1090-1099
7. Boucher RC (2007) Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 58:157-170
8. Chen JH, Stoltz DA, Karp PH, Ernst SE, Pezzulo AA, Moninger TO, Rector MV, Reznikov LR, Launspach JL, Chaloner K et al (2010) Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia. Cell 143:911-923
9. Tirouvanziam R, de Bentzmann S, Hubeau C, Hinnrasky J, Jacquot J, Peault B, Puchelle E (2000) Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 23:121-127
10. Inoue H, Massion PP, Ueki IF, Grattan KM, Hara M, Dohrman AF, Chan B, Lausier JA, Golden JA, Nadel JA (1994) Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils. Am J Respir Cell Mol Biol 11:651-663
11. Oceandy D, McMorran BJ, Smith SN, Schreiber R, Kunzelmann K, Alton EW, Hume DA, Wainwright BJ (2002) Gene complementation of airway epithelium in the cystic fibrosis mouse is necessary and sufficient to correct the pathogen clearance and inflammatory abnormalities. Hum Mol Genet 11:1059-1067
12. Teichgräber V, Ulrich M, Endlich N, Riethmüller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von Kürthy G, Schmid KW et al (2008) Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14:382-391
13. Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M (1995) Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 13:257-261
14. Brodlie M, McKean MC, Johnson GE, Gray J, Fisher AJ, Corris PA, Lordan JL, Ward C (2010) Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 182:369-375
15. Becker KA, Riethmüller J, Luth A, Döring G, Kleuser B, Gulbins E (2010) Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am J Respir Cell Mol Biol 42:716-724
16. Ulrich M, Worlitzsch D, Viglio S, Siegmann N, Iadarola P, Shute JK, Geiser M, Pier GB, Friedel G, Barr ML et al (2010) Alveolar inflammation in cystic fibrosis. J Cyst Fibros 9:217-227
17. Bodas M, Min T, Vij N (2011) Critical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury. Am J Physiol Lung Cell Mol Physiol 300:L811-L820
18. Bodas M, Min T, Mazur S, Vij N (2011) Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulatordependent ceramide signaling in lung injury and emphysema. J Immunol 186:602-613
19. Zhang Y, Li X, Carpinteiro A, Gulbins E (2008) Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosainduced macrophage apoptosis. J Immunol 181:4247-4254
20. Becker KA, Tümmler B, Gulbins E, Grassmé H (2010) Accumulation of ceramide in the trachea and intestine of cystic fibrosis causes inflammation and cell death. Biochem Biophys Res Commun 403:368-374
21. Kumar V, Becker T, Jansen S, van Barneveld A, Boztug K, Wolfl S, Tummler B, Stanke F (2008) Expression levels of FAS are regulated through an evolutionary conserved element in intron 2, which modulates cystic fibrosis disease severity. Genes Immun 9:689-696
22. Stanke F, Becker T, Kumar V, Hedtfeld S, Becker C, Cuppens H, Tamm S, Yarden J, Laabs U, Siebert B et al (2011) Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia. J Med Genet 48:24-31
23. Grassmé H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R, Gulbins E (2001) CD95 signaling via ceramide-rich membrane rafts. J Biol Chem 276:20589-20596
24. Grassmé H, Jendrossek V, Riehle A, von Kürthy G, Berger J, Schwarz H, Weller M, Kolesnick R, Gulbins E (2003) Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9:322-330
25. Adachi M, Watanabe-Fukunaga R, Nagata S (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci U S A 90:1756-1760
26. Gulbins E, Kolesnick R (2003) Raft ceramide in molecular medicine. Oncogene 22:7070-7077
27. Durieu I, Amsellem C, Paulin C, Chambe MT, Bienvenu J, Bellon G, Pacheco Y (1999) Fas and Fas ligand expression in cystic fibrosis airway epithelium. Thorax 54:1093-1098
28. Rottner M, Kunzelmann C, Mergey M, Freyssinet JM, Martinez MC (2007) Exaggerated apoptosis and NF-kappaB activation in pancreatic and tracheal cystic fibrosis cells. FASEB J 21:2939-2948
29. Amsellem C, Durieu CMT, Peyrol S, Pacheco Y (2002) In vitro expression of fas and CD40 and induction of apoptosis in human cystic fibrosis airway epithelial cells. Respir Med 96:244-249
30. Pier GB, Grout M, Zaidi TS, Olsen JC, Johnson LG, Yankaskas JR, Goldberg JB (1996) Role of the mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271:64-67
31. Gadjeva M, Paradis-Bleau C, Priebe G, Fichorova R, Pier GB (2010) Caveolin-1 modifies the immunity to P. aeruginosa. J Immunol 184:296-302
32. Krammer PH, Kaminski M, Kiessling M, Gulow K (2007) No life without death. Adv Cancer Res 97:111-138
33. Green DR, Droin N, Pinkoski M (2003) Activation-induced cell death in T cells. Immunol Rev 193:70-81
34. Miwa K, Asano M, Horai R, Iwakura Y, Nagata S, Suda T (1998) Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 4:1287-1292
35. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140:821-832
36. Lamkanfi M, Dixit VM (2009) The inflammasomes. PLoS Pathog 5:e1000510
37. Brodsky IE, Monack D (2009) NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. Semin Immunol 21:199-207
38. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G (2009) The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10:241-247
39. Mrugacz M (2009) Fas expression in conjunctival epithelial cells of patients with cystic fibrosis. J Interferon Cytokine Res 29:735-740